Keywords: درمان دارویی کمک; Benzodiazepines; Buprenorphine; Medication-Assisted treatment; Concomitant use;
مقالات ISI درمان دارویی کمک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان دارویی کمک; Opioid dependence; Medication-assisted treatment; Heroin-assisted treatment; Diacetylmorphine; Employment; Education;
Keywords: درمان دارویی کمک; ASSIST; Alcohol, Smoking and Substance Involvement Screening Test; AUD; Alcohol use disorder; BT; Brief treatment; BUP/NX; Buprenorphine/naloxone; CC; Collaborative care; CI; Confidence interval; CIDI; Comprehensive International Diagnostic Interview; DSM
Keywords: درمان دارویی کمک; Naltrexone; Alcohol use disorder; Extended-release naltrexone; Alcohol; Treatment outcomes; Medication-assisted treatment;
Keywords: درمان دارویی کمک; Screening and brief intervention; Collaborative care; Behavioral health integration; Medication-assisted treatment;
Keywords: درمان دارویی کمک; Opioid use disorder; Family homelessness; Outreach medicine; Qualitative research; Innovative treatment models; Medication-assisted treatment;
Keywords: درمان دارویی کمک; Buprenorphine; Medication-assisted treatment; Opioid use; Diversion;
Keywords: درمان دارویی کمک; Maintenance therapy; Medication-assisted treatment; Subjective; Heroin; Opiate; Substance use;
Keywords: درمان دارویی کمک; Buprenorphine; methadone; medication-assisted treatment; opioid; substance use disorder;
Keywords: درمان دارویی کمک; acute pain management; chronic opioid therapy; medication-assisted treatment; multimodal analgesia; opioid tolerant; opioid use disorder;
Keywords: درمان دارویی کمک; GC-MS; gas chromatography-mass spectrometry; LC-MS-MS; liquid chromatography tandem mass spectrometry; LOQ; limit of quantitation; MAT; medication-assisted treatment; OTP; opioid treatment program; OUD; opioid use disorder; THC; tetrahydrocannabidiol;
Keywords: درمان دارویی کمک; buprenorphine; medication-assisted treatment; methadone; opioid; pregnancy;
Keywords: درمان دارویی کمک; Long-acting reversible contraception; Opioid use disorder; Medication-assisted treatment; Unintended pregnancy;
Keywords: درمان دارویی کمک; Opioids; Medication-assisted treatment; Child welfare;
Keywords: درمان دارویی کمک; Medication-assisted treatment; MAT; Opioid; Addiction; Medicaid;
Keywords: درمان دارویی کمک; Substance use disorders; Pharmacotherapy; Medication-assisted treatment; Insurance; Health plans; Access;
Keywords: درمان دارویی کمک; Substance abuse; Extended-release naltrexone; Medication-assisted treatment; Opioids; Alcohol;
Keywords: درمان دارویی کمک; Substance use disorder; Evidence-based practices; Latent class analysis; Medication-assisted treatment; Motivational interviewing;
Keywords: درمان دارویی کمک; Prison; Jail; Ethics; Medication-assisted treatment; Opioid;
Keywords: درمان دارویی کمک; Opioids; Heroin; Buprenorphine; Methadone; Medication-assisted treatment; Substance use;
Keywords: درمان دارویی کمک; Harm reduction; Infective endocarditis; Injection drug use; Medication-assisted treatment; Substance use disorder
Keywords: درمان دارویی کمک; Opioid use disorder; Extended-release naltrexone; Heroin; Opioids; Medication-assisted treatment
Keywords: درمان دارویی کمک; Heroin shortage; KENYA; HIV; Medication-assisted treatment; Drug treatment
History of postpartum depression as a contributor to the severity of NAS
Keywords: درمان دارویی کمک; NAS; Neonatal Abstinence Syndrome; SUD; Substance Use Disorder; MAT; medication-assisted treatment; CHH; Cabell Huntington Hospital; UDS; Urine Drug Screen; NICU; Neonatal Intensive Care Unit; NTU; Neonatal Therapeutic Unit; PPD; Postpartum Depression;
The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010-2015)
Keywords: درمان دارویی کمک; SUD treatment system development; Extended-release naltrexone; Injectable naltrexone; Medication-assisted treatment; Alcohol use disorder; Opioid use disorder;
A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine
Keywords: درمان دارویی کمک; Patient preferences; Addiction; Medication-assisted treatment; Opioid use disorders; Extended-release naltrexone (Vivitrol®); Ukraine; HIV; People who inject drugs; Implementation science;
A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices
Keywords: درمان دارویی کمک; Opioid use disorder; Medication-assisted treatment; Buprenorphine; Extended-release naltrexone;
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Keywords: درمان دارویی کمک; Opioid use disorders; Buprenorphine; Medication-assisted treatment; Medicaid;
Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data
Keywords: درمان دارویی کمک; COD; cause of death; CSMD; controlled substance monitoring database; DOB; date of birth; DEA; drug enforcement administration; IMF; illicitly manufactured fentanyl; MAT; medication-assisted treatment; MME; morphine milligram equivalents; MCOD; multiple ca
Short CommunicationHeroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification
Keywords: درمان دارویی کمک; Heroin dependence; Refusal self-efficacy; Opioid detoxification; Medication-assisted treatment;
Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic
Keywords: درمان دارویی کمک; HIV; Opioid use disorders; Medication-assisted treatment; Opioid agonist treatment; Methadone; Buprenorphine; Retention;
Opioid Use Disorder in the Hospitalized Patient
Keywords: درمان دارویی کمک; Opioid use disorder; Heroin; Controlled prescription drugs; Opioid withdrawal; Opioid maintenance therapy; Medication-assisted treatment; Harm-reduction strategies;
Treatment utilization among persons with opioid use disorder in the United States
Keywords: درمان دارویی کمک; Heroin use disorder; Medication-assisted treatment; Opioid use disorder; Prescription opioid misuse; Substance use treatment;
Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives
Keywords: درمان دارویی کمک; American Indians/Alaska Natives; Medication-assisted treatment; Opioid use disorder; Indigenous; Two-eyed seeing; Implementation;
Medication-assisted treatment for opioid addiction: Methadone and buprenorphine
Keywords: درمان دارویی کمک; Buprenorphine; Medication-assisted treatment; Methadone; Opioid addiction
Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes
Keywords: درمان دارویی کمک; Drug courts; Methadone; Buprenorphine; Naltrexone; Medication-assisted treatment
Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
Keywords: درمان دارویی کمک; Medication-assisted treatment; Disulfiram; Tablet naltrexone; Acamprosate; Buprenorphine; Injectable naltrexone
Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure
Keywords: درمان دارویی کمک; Medication-assisted treatment; Treatment of substance use disorders; Barriers to implementation
Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention
Keywords: درمان دارویی کمک; Prison; Incarceration; Opioid-substitution therapy; Methadone; Buprenorphine; Human rights; Medication-assisted treatment